An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective-Reference-Cited by-同舟云学术

An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective

Published:2023-09 Issue:9 Volume:4 Page:528-537
ISSN:2666-5018
Container-title:Heart Rhythm O2
language:en
Short-container-title:Heart Rhythm O2

Author:

Wazni Oussama,Moss Joe,Kuniss Malte,Andrade Jason,Chierchia Gian Battista,Mealing Stuart,Mburu Waruiru,Sale Alicia,Kaplon Rachelle,Ismyrloglou Eleni,Bromilow Tom,Lane Emily,Lewis Damian,Reynolds Matthew R.

Funder

Medtronic

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge;Lippi;Int J Stroke,2021

2. Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies;Adderley;BMJ,2018

4. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

5. Early rhythm-control therapy in patients with atrial fibrillation;Kirchhof;N Engl J Med,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation;BMC Cardiovascular Disorders;2024-07-16

2. Safety and Efficacy of Second-Generation Cryoballoon Ablation in Patients Aged over 75 Years;The Heart Surgery Forum;2024-05-15

3. An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation Population;PharmacoEconomics - Open;2024-01-20

4. Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English National Health Service perspective;Open Heart;2024-01

5. The Cost-Effectiveness of First-Line Cryoablation versus First-Line Antiarrhythmic Drugs in Canadian Patients with Paroxysmal Atrial Fibrillation;Canadian Journal of Cardiology;2023-11